DekaBank Deutsche Girozentrale - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$1,627,000
+111.8%
24,2500.0%0.01%
+150.0%
Q2 2022$768,000
-9.4%
24,2500.0%0.00%0.0%
Q1 2022$848,000
+28.7%
24,250
+10.0%
0.00%0.0%
Q4 2021$659,000
+20.3%
22,050
+2.8%
0.00%0.0%
Q3 2021$548,000
-20.1%
21,4500.0%0.00%0.0%
Q2 2021$686,000
-20.6%
21,4500.0%0.00%
-33.3%
Q1 2021$864,000
-7.9%
21,4500.0%0.00%
-25.0%
Q4 2020$938,000
-21.8%
21,450
-4.9%
0.00%
-20.0%
Q3 2020$1,200,000
-22.3%
22,550
-21.2%
0.01%
-37.5%
Q2 2019$1,544,000
+80.0%
28,600
+63.4%
0.01%
+60.0%
Q1 2019$858,000
+50.3%
17,500
+22.4%
0.01%
+25.0%
Q4 2018$571,000
-33.4%
14,300
-18.3%
0.00%
-20.0%
Q3 2018$858,000
+0.5%
17,500
-2.8%
0.01%
-16.7%
Q2 2018$854,000
-0.6%
18,0000.0%0.01%0.0%
Q1 2018$859,000
+305.2%
18,000
+143.2%
0.01%
+200.0%
Q4 2017$212,0000.0%7,4000.0%0.00%0.0%
Q3 2017$212,000
+0.5%
7,4000.0%0.00%0.0%
Q2 2017$211,0007,4000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 460,000$14,872,00013.19%
VHCP Management II, LLC 141,611$4,578,0003.76%
Perceptive Advisors 1,186,630$38,363,0002.84%
RTW INVESTMENTS, LP 175,156$5,663,0001.87%
Casdin Capital, LLC 65,000$2,101,0001.86%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,163,811$37,626,0001.52%
RA Capital Management 457,142$14,779,0001.46%
VHCP Management, LLC 60,691$1,962,0001.19%
Iguana Healthcare Management, LLC 110,000$3,556,0001.17%
Partner Investment Management, L.P. 15,634$505,0000.83%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders